Divalproex sodium extended-release tablets for migraine prophylaxis in adolescents: an open-label, long-term safety study

Trial Profile

Divalproex sodium extended-release tablets for migraine prophylaxis in adolescents: an open-label, long-term safety study

Completed
Phase of Trial: Phase III

Latest Information Update: 31 Aug 2007

At a glance

  • Drugs Valproate semisodium; Valproic acid
  • Indications Migraine
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Aug 2007 Status changed from in progress to completed.
    • 29 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top